Compare Agilent Technologies Inc (A) vs Teucrium Soybean Fund (SOYB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Teucrium Soybean Fund — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while Teucrium Soybean Fund trades at $24.82. The key difference: Agilent Technologies Inc pays a 0.69% dividend while Teucrium Soybean Fund pays none, and Agilent Technologies Inc is trading nearer its 52-week high, Teucrium Soybean Fund nearer its low. Which is the better fit depends on your goals.
| A | SOYB | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $157.20 | $26.28 |
52-Week Low | $110.24 | $21.46 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
SOYB trades at $25.04, showing minimal daily change of 0.03%. Technical indicators suggest a bearish bias with moving averages signaling caution, though oscillators are neutral. Recent news highlights potential agricultural sector tailwinds from China's $17 billion crop purchase pledge through 2028, which could benefit U.S. exporters like SOYB. However, key financial ratios including P/E, P/S, and profitability metrics are currently unavailable, limiting fundamental clarity.
The stock faces near-term technical headwinds but may find support from positive agricultural trade developments. Investment opportunity hinges on improved financial disclosure and sector momentum, while risks include geopolitical tensions and lack of transparent fundamentals. Investors require updated earnings reports to assess valuation properly.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →
